Inari Medical, Inc.

NasdaqGS NARI

Inari Medical, Inc. Price to Earnings Ratio (P/E) on January 14, 2025: -59.10

Inari Medical, Inc. Price to Earnings Ratio (P/E) is -59.10 on January 14, 2025, a 97.18% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Inari Medical, Inc. 52-week high Price to Earnings Ratio (P/E) is -30.19 on October 07, 2024, which is 48.92% above the current Price to Earnings Ratio (P/E).
  • Inari Medical, Inc. 52-week low Price to Earnings Ratio (P/E) is -2,097.20 on February 15, 2024, which is -3,448.73% below the current Price to Earnings Ratio (P/E).
  • Inari Medical, Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is -433.16.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
NasdaqGS: NARI

Inari Medical, Inc.

CEO Mr. Andrew J. Hykes
IPO Date May 22, 2020
Location United States
Headquarters 6001 Oak Canyon
Employees 1,300
Sector Health Care
Industries
Description

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Similar companies

OM

Outset Medical, Inc.

USD 0.81

0.53%

LEGN

Legend Biotech Corporation

USD 31.64

-2.65%

PGNY

Progyny, Inc.

USD 20.04

-1.28%

StockViz Staff

January 15, 2025

Any question? Send us an email